Global Market: Hong Kong stocks rise as pharma, tech shares lead gains
Hong Kong stocks gained on Tuesday, led by pharmaceutical and technology shares, with the Hang Seng rising 0.78% and Hang Seng Tech Index advancing 0.87%. Biotech firms WuXi Biologics and Sino Biopharmaceutical rallied over 4%. Property stocks remained weak amid residential market concerns, debt pressures and refinancing risks among developers.
Key Takeaways
- Hong Kong stocks gained on Tuesday, led by pharmaceutical and technology shares, with the Hang Seng rising 0.78% and Hang Seng Tech Index advancing 0.87%.
- Biotech firms WuXi Biologics and Sino Biopharmaceutical rallied over 4%.
- Property stocks remained weak amid residential market concerns, debt pressures and refinancing risks among developers.
Hong Kong stocks gained on Tuesday, led by pharmaceutical and technology shares, with the Hang Seng rising 0.78% and Hang Seng Tech Index advancing 0.87%. Biotech firms WuXi Biologics and Sino Biopharmaceutical rallied over 4%. Property stocks remained weak amid residential market concerns, debt pressures and refinancing risks among developers.
Original Publisher Attribution
This summary was curated from Economic Times.